Credit:
Wei Chen, Stephenson Chair and Professor in the Stephenson School of Biomedical Engineering at the University of Oklahoma, has worked for more than two decades to develop a novel therapy, localized ablative immunotherapy (LAIT), to treat metastatic cancers.